Rachel Bulotsky Dinges

Rachel Bulotsky Dinges is a seasoned professional in the biopharmaceutical industry, currently serving as Sr. Director of Cell Therapy Technical Operations at Bristol Myers Squibb since January 2015. In this role, Rachel leads the Manufacturing Technology organization at the Devens Cell Therapy Facility, which is currently under construction. Previously, Rachel held various positions at Pfizer from January 2008 to December 2014, including Associate Director of Global Biologics Stability and Technical Product Team Leader, and earlier at Genentech, Inc. from April 2001 to January 2008, starting as Engineer II. Rachel earned a Bachelor of Science degree in Chemical Engineering from Rensselaer Polytechnic Institute between 1996 and 2001.